Zolpidem

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcComparative bioavailability of two zolpidem hemitartrate formulations in healthy human Brazilian volunteers
3. 2026-09-24srcAre Seniors Dependent on Benzodiazepines? A National Clinical Survey of Substance Use Disorder
4. 2026-09-24srcThe effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam
5. 2026-09-24srcSleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour
6. 2026-09-24srcRelationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects
7. 2026-09-24srcBenzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research
8. 2026-09-24srcProbing the molecular basis for affinity/potency- and efficacy-based subtype-selectivity exhibited by benzodiazepine-site modulators at GABAA receptors
9. 2026-09-24srcReview of Safety and Efficacy of Sleep Medicines in Older Adults
10. 2026-09-24srcSublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep
11. 2026-09-24srcEfficacy and safety of insomnia pharmacotherapies: Convergent evidence from Bayesian network meta-regression and FAERS-based disproportionality analysis
12. 2026-09-24srcExamination of Zolpidem effects on AhR- and PXR-dependent expression of drug-metabolizing cytochromes P450 in primary cultures of human hepatocytes
13. 2026-09-24srcAcute effects of zolpidem extended-release on cognitive performance and sleep in healthy males after repeated nightly use
14. 2026-09-24srcThe efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial
15. 2026-09-24srcStructural and dynamic mechanisms of GABAA receptor modulators with opposing activities
16. 2026-09-24srcAssessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study
17. 2026-09-24srcZolpidem and eszopiclone prime a1b2g2 GABAA receptors for longer duration of activity
18. 2026-09-24srcDrug interaction between St John's wort and zolpidem in healthy subjects
19. 2026-09-24srcThe European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023
20. 2026-09-24srcSedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
21. 2026-09-24srcEffects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers
22. 2026-09-24srcSex differences in pharmacokinetics predict adverse drug reactions in women
23. 2026-09-24srcZolpidem for insomnia
24. 2026-09-24srcComparative tolerability of newer agents for insomnia
25. 2026-09-24srcZolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
26. 2026-09-24srcEffects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial
27. 2026-09-24srcAssociation Between Z Drugs Use and Risk of Cognitive Impairment in Middle-Aged and Older Patients With Chronic Insomnia
28. 2026-09-24srcCase report: Chronological symptom profile after cessation of overdose zolpidem in a patient with comorbid bipolar disorder
29. 2026-09-24srcZolpidem withdrawal induced uncoupling of GABA(A) receptors in vitro associated with altered GABA(A) receptor subunit mRNA expression
30. 2026-09-24srcComparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes
31. 2026-09-24srcSpontaneous Adverse Event Reports Associated with Zolpidem in the United States 2003-2012
32. 2026-09-24srcClinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.
33. 2026-09-24srcComparison of lemborexant with placebo and zolpidem tartrate extended release on sleep architecture in older adults
34. 2026-09-24srcRegional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha1 versus alpha2 and alpha3 subunit-containing GABAA receptors
35. 2026-09-24srcIndependence of sleep EEG responses to GABAergic hypnotics: biological implications
36. 2026-09-24srcNew drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon
37. 2026-09-24srcNewer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
38. 2026-09-24srcZolpidem extended-release
39. 2026-09-24srcHPLC quantification of zolpidem and prothipendyl in a voluntary intoxication
40. 2026-09-24srcLow-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night awakenings
41. 2026-09-24srcZolpidem intoxication mimicking narcotic overdose: response to flumazenil
42. 2026-09-24srcZolpidem dependence and withdrawal seizure--report of two cases
43. 2026-09-24srcSilencing the brain may be better than stimulating it. The GABA effect
44. 2026-09-24srcZolpidem dependence, abuse and withdrawal: A case report
45. 2026-09-24srcZolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients
46. 2026-09-24srcClinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications
47. 2026-09-24srcZolpidem - StatPearls
48. 2026-09-24srcFDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, Zolpimist)
49. 2026-09-04issueIssued emergency
50. 2026-09-04issueIssued info_card
51. 2026-09-04issueIssued notice
52. 2026-06-04proposal36 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
53. 2026-06-04publicationPublication — backfill
54. 2026-04-28revisionRevision 1
55. 2026-04-28genGeneration — pipeline-v5 · with 2 morepipeline-v5
56. 2026-04-28rungeneration run

The same entries, as forms: six forms.